CAMBRIDGE, MA – May 15, 2025 – Arbor Biotechnologies, Inc., a biotechnology company discovering and developing the next generation of genetic medicines, today announced the presentation of four posters showcasing Arbor’s commitment to CNS diseases of high unmet need and Read More The post Arbor Biotechnologies to Present Data on CNS Programs and Platform Advances at the American Society of Gene and Cell Therapy (ASGCT) 28th Annual Meeting appeared first on Arbor Biotechnologies .